Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Edwards Lifesciences Corp (EW)

Edwards Lifesciences Corp (EW)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 48,128,976
  • Shares Outstanding, K 621,741
  • Annual Sales, $ 4,348 M
  • Annual Income, $ 1,047 M
  • 60-Month Beta 0.88
  • Price/Sales 11.17
  • Price/Cash Flow 38.42
  • Price/Book 12.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.44
  • Number of Estimates 12
  • High Estimate 0.47
  • Low Estimate 0.33
  • Prior Year 0.47
  • Growth Rate Est. (year over year) -6.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.87 +15.76%
on 07/10/20
80.50 -3.84%
on 07/24/20
+7.88 (+11.33%)
since 07/06/20
3-Month
66.23 +16.88%
on 06/15/20
80.50 -3.84%
on 07/24/20
+6.17 (+8.67%)
since 05/06/20
52-Week
51.51 +50.29%
on 03/23/20
82.55 -6.22%
on 11/19/19
+6.50 (+9.17%)
since 08/06/19

Most Recent Stories

More News
TMO vs. EW: Which Stock Is the Better Value Option?

TMO vs. EW: Which Stock Is the Better Value Option?

TMO : 415.73 (-0.99%)
EW : 77.41 (-0.91%)
InnovHeart Appoints J. Brent Ratz as Chief Executive Officer and Member of the Board

InnovHeart s.r.l., a developer of novel Transcatheter Mitral Valve Replacement (TMVR) systems for the treatment of mitral regurgitation, announced today the appointment of veteran medical device executive...

EW : 77.41 (-0.91%)
Look for Shares of Edwards Life to Potentially Rebound after Yesterday's 1.42% Sell Off

Edwards Life (NYSE:EW) traded in a range yesterday that spanned from a low of $76.87 to a high of $77.94. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $77.42 on...

EW : 77.41 (-0.91%)
Thrombectomy Devices Market Research Report by Type, by Utility, by Technology, by Indication, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19

, /PRNewswire/ --Read the full report: The Global Thrombectomy Devices Market is expected to grow from in 2019 to by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 6.35%.Market Segmentation...

BSX : 37.89 (+0.42%)
EW : 77.41 (-0.91%)
MDT : 96.73 (-0.30%)
PEN : 232.75 (-1.41%)
SPNC : 38.45 (unch)
SYK : 188.59 (+0.34%)
TFX : 369.57 (-1.25%)
Hemodynamic Monitoring Markets in North America, 2020-2025 with Getinge, Koninklijke Philips, Edwards Life Sciences, and GE Healthcare Dominating

, /PRNewswire/ -- The report has been added to offering.

EW : 77.41 (-0.91%)
LDRUF : 0.0200 (-75.00%)
Bioprosthetic Valve Market 2020 Size, Global Trends, Comprehensive Research Study, Development Status, Opportunities, Future Plans, Competitive Landscape and Growth by Forecast 2026

A recent report provides crucial insights along with application based and forecast information in the Global Bioprosthetic Valve Market. The report provides a comprehensive analysis of key factors that...

BSX : 37.89 (+0.42%)
CRY : 20.45 (+1.14%)
EW : 77.41 (-0.91%)
LIVN : 47.06 (-0.68%)
MDT : 96.73 (-0.30%)
NVCN.TO : 3.54 (-5.85%)
Edwards Lifesciences (EW) Beats on Q2 Earnings, Ups EPS View

Despite coronavirus-hit sales, Edwards Lifesciences (EW) witnessed steady improvement in TAVR procedure volumes in Q2. Regulatory approvals look encouraging.

EW : 77.41 (-0.91%)
RMD : 175.52 (-13.52%)
EXAS : 90.40 (-1.68%)
VRAY : 3.17 (-5.65%)
Bear of the Day: Penumbra (PEN)

Bear of the Day: Penumbra (PEN)

PEN : 232.75 (-1.41%)
MDT : 96.73 (-0.30%)
JNJ : 147.55 (-0.57%)
EW : 77.41 (-0.91%)
ABT : 101.75 (-0.38%)
Edwards Lifesciences (EW) Q2 Earnings and Revenues Beat Estimates

Edwards Lifesciences (EW) delivered earnings and revenue surprises of 126.67% and 18.15%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

EW : 77.41 (-0.91%)
Edwards Lifesciences: 2Q Earnings Snapshot

IRVINE, Calif. (AP) _ Edwards Lifesciences Corp. (EW) on Thursday reported a second-quarter loss of $121.9 million, after reporting a profit in the same period a year earlier.

EW : 77.41 (-0.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Trade EW with:

Business Summary

Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards...

See More

Key Turning Points

2nd Resistance Point 78.48
1st Resistance Point 77.95
Last Price 77.41
1st Support Level 76.69
2nd Support Level 75.96

See More

52-Week High 82.55
Last Price 77.41
Fibonacci 61.8% 70.69
Fibonacci 50% 67.03
Fibonacci 38.2% 63.36
52-Week Low 51.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar